Cargando…
Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function
As a first-line treatment for diabetes, the insulin-sensitizing biguanide, metformin, regulates glucose levels and positively affects cardiovascular function in patients with diabetes and cardiovascular complications. Endothelial dysfunction (ED) represents the primary pathological change of multipl...
Autores principales: | Ding, Yu, Zhou, Yongwen, Ling, Ping, Feng, Xiaojun, Luo, Sihui, Zheng, Xueying, Little, Peter J., Xu, Suowen, Weng, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490502/ https://www.ncbi.nlm.nih.gov/pubmed/34646376 http://dx.doi.org/10.7150/thno.64706 |
Ejemplares similares
-
Metformin, Macrophage Dysfunction and Atherosclerosis
por: Feng, Xiaojun, et al.
Publicado: (2021) -
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
por: Jiang, Hui, et al.
Publicado: (2022) -
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021) -
Targeting inflammation and cytokine storm in COVID-19
por: Huang, Qianwen, et al.
Publicado: (2020) -
The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction
por: Xu, Suowen, et al.
Publicado: (2021)